| Healthy | CTEPH | PE |
---|---|---|---|
N = 4 | N = 6 | N = 6 | |
Males/females | 2/2 | 2/4 | 2/4 |
Age, years | 54 (42–60) | 68 (52–81) | 68 (45–91) |
mPAP, mmHg | - | 42 (30–57) | - |
Warfarin/anticoagulants | - | 6 | 6 |
Ca channel blockers | - | 1 | 1 |
statins | - | 2 | 2 |
paracetamol/aspirin | - | 3 | 4 |
ET-1 antagonists | - | 5 | - |
Diuretics | - | 4 | 1 |
ACE inhibitors | - | 2 | 1 |
Angiotensin II antagonists | - | - | 1 |
β-blockers | - | 1 | 4 |